Form 8-K - Current report:
SEC Accession No. 0001104659-22-032980
Filing Date
2022-03-11
Accepted
2022-03-11 17:24:57
Documents
15
Period of Report
2022-03-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm228792d2_8k.htm   iXBRL 8-K 25224
2 EXHIBIT 99.1 tm228792d2_ex99-1.htm EX-99.1 97094
6 GRAPHIC tm228792d2_ex99-1img01.jpg GRAPHIC 2438
7 GRAPHIC image_010.jpg GRAPHIC 2433
  Complete submission text file 0001104659-22-032980.txt   321535

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA jagx-20220311.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20220311_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20220311_pre.xml EX-101.PRE 22615
9 EXTRACTED XBRL INSTANCE DOCUMENT tm228792d2_8k_htm.xml XML 3604
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 22734157
SIC: 2834 Pharmaceutical Preparations